Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $147 | In Stock | In Stock | |
| 5 mg | $368 | In Stock | In Stock | |
| 10 mg | $543 | - | In Stock | |
| 25 mg | Preferential | - | In Stock | |
| 50 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $417 | - | In Stock |
| Description | Epimedokoreanin B is a natural isopentenylflavonoid compound isolated from Korean horny goat weed (Epimedium koreanum Nakai) that exhibits anticancer, anti-inflammatory, and antibacterial activities. Epimedokoreanin B is an anti-periodontitis agent that inhibits the growth and biofilm formation of gingival proteases and Porphyromonas gingivalis. Epimedokoreanin B can inhibit the growth of lung cancer cells through endoplasmic reticulum stress-mediated apoptosis accompanied by autophagy. |
| Targets & IC50 | HNE:6.06 μM, Bacterial Nucleic Acid:0.17 µM |
| In vitro | Methods: Human myeloma cells U266 and RPMI-8226 were treated with Epimedokoreanin B at gradient concentrations (5, 10, 15 μM) for 48 hours. Apoptosis was assessed via Annexin V/PI double staining. Results: Cells exhibited concentration-dependent apoptosis induction. At 15 μM, the apoptosis rate reached 62.2% in U266 cells and 51.81% in RPMI-8226 cells. [1] Methods: Human osteosarcoma cells (Saos-2) and mouse osteosarcoma cells (LM8) were treated with Epimedokoreanin B at gradient concentrations (5, 10, 20 μM) for 48–72 hours. Proliferation was assessed using MTT assay or cell counting. Results: Concentration-dependent inhibition of proliferation was observed in both osteosarcoma cell lines, accompanied by decreased STAT3 phosphorylation levels. [2] |
| In vivo | Methods: LM8 mouse osteosarcoma cells were subcutaneously implanted into C3H mice to establish a tumor model. Once tumors became palpable, Epimedokoreanin B oral gavage administration commenced at doses of 10 mg/kg or 30 mg/kg, once daily for 14 consecutive days. Results: Tumor growth was significantly slowed, with marked reductions in tumor volume and weight observed in both dose groups.[2] |
| Molecular Weight | 422.47 |
| Formula | C25H26O6 |
| Cas No. | 161068-53-7 |
| Smiles | C(C=C(C)C)C1=C2C(C(=O)C=C(O2)C3=CC(CC=C(C)C)=C(O)C(O)=C3)=C(O)C=C1O |
| Relative Density. | 1.301 g/cm3 (Predicted) |
| Storage | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 33.33 mg/mL (78.89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.